These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
751 related items for PubMed ID: 9658403
1. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells. Le Bihan S, Marsaud V, Mercier-Bodard C, Baulieu EE, Mader S, White JH, Renoir JM. Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403 [Abstract] [Full Text] [Related]
3. Effects of immunosuppressants FK506 and rapamycin on the heterooligomeric form of the progesterone receptor. Renoir JM, Le Bihan S, Mercier-Bodard C, Gold A, Arjomandi M, Radanyi C, Baulieu EE. J Steroid Biochem Mol Biol; 1994 Jan; 48(1):101-10. PubMed ID: 7510997 [Abstract] [Full Text] [Related]
4. Dexamethasone and triamcinolone acetonide accumulation in mouse fibroblasts is differently modulated by the immunosuppressants cyclosporin A, FK506, rapamycin and their analogues, as well as by other P-glycoprotein ligands. Marsaud V, Mercier-Bodard C, Fortin D, Le Bihan S, Renoir JM. J Steroid Biochem Mol Biol; 1998 Jul; 66(1-2):11-25. PubMed ID: 9712407 [Abstract] [Full Text] [Related]
5. Cyclosporin A potentiates the dexamethasone-induced mouse mammary tumor virus-chloramphenicol acetyltransferase activity in LMCAT cells: a possible role for different heat shock protein-binding immunophilins in glucocorticosteroid receptor-mediated gene expression. Renoir JM, Mercier-Bodard C, Hoffmann K, Le Bihan S, Ning YM, Sanchez ER, Handschumacher RE, Baulieu EE. Proc Natl Acad Sci U S A; 1995 May 23; 92(11):4977-81. PubMed ID: 7539138 [Abstract] [Full Text] [Related]
7. Immunological identification of a 50 kDa Mr FK506-binding immunophilin as a component of the non-DNA binding, hsp90 and hsp70 containing, heterooligomeric form of the chick oviduct progesterone receptor. Renoir JM, Pahl A, Keller U, Baulieu EE. C R Acad Sci III; 1993 Dec 23; 316(12):1410-6. PubMed ID: 7522118 [Abstract] [Full Text] [Related]
8. In vivo evidence for the generation of a glucocorticoid receptor-heat shock protein-90 complex incapable of binding hormone by the calmodulin antagonist phenoxybenzamine. Ning YM, Sánchez ER. Mol Endocrinol; 1996 Jan 23; 10(1):14-23. PubMed ID: 8838141 [Abstract] [Full Text] [Related]
9. Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors. Beck CA, Weigel NL, Edwards DP. Mol Endocrinol; 1992 Apr 23; 6(4):607-20. PubMed ID: 1316549 [Abstract] [Full Text] [Related]
11. Heat shock alters the composition of heteromeric steroid receptor complexes and enhances receptor activity in vivo. Edwards DP, Estes PA, Fadok VA, Bona BJ, Oñate S, Nordeen SK, Welch WJ. Biochemistry; 1992 Mar 10; 31(9):2482-91. PubMed ID: 1312348 [Abstract] [Full Text] [Related]
12. Agonist-specific modulation of glucocorticoid receptor-mediated transcription by immunosuppressants. Medh RD, Lay RH, Schmidt TJ. Mol Cell Endocrinol; 1998 Mar 16; 138(1-2):11-23. PubMed ID: 9685211 [Abstract] [Full Text] [Related]
13. Induction of differentiation of human myeloid leukemia cells by immunosuppressant macrolides (rapamycin and FK506) and calcium/calmodulin-dependent kinase inhibitors. Yamamoto-Yamaguchi Y, Okabe-Kado J, Kasukabe T, Honma Y. Exp Hematol; 2001 May 16; 29(5):582-8. PubMed ID: 11376870 [Abstract] [Full Text] [Related]
14. Potentiation of progesterone receptor-mediated transcription by the immunosuppressant FK506. Tai PK, Albers MW, McDonnell DP, Chang H, Schreiber SL, Faber LE. Biochemistry; 1994 Sep 06; 33(35):10666-71. PubMed ID: 7521210 [Abstract] [Full Text] [Related]
15. Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506. Davies TH, Ning YM, Sánchez ER. Biochemistry; 2005 Feb 15; 44(6):2030-8. PubMed ID: 15697228 [Abstract] [Full Text] [Related]
16. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors. Beck CA, Estes PA, Bona BJ, Muro-Cacho CA, Nordeen SK, Edwards DP. Endocrinology; 1993 Aug 15; 133(2):728-40. PubMed ID: 8344212 [Abstract] [Full Text] [Related]
17. Rapamycin potentiates dexamethasone-induced apoptosis and inhibits JNK activity in lymphoblastoid cells. Ishizuka T, Sakata N, Johnson GL, Gelfand EW, Terada N. Biochem Biophys Res Commun; 1997 Jan 13; 230(2):386-91. PubMed ID: 9016789 [Abstract] [Full Text] [Related]
18. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells. Gougelet A, Bouclier C, Marsaud V, Maillard S, Mueller SO, Korach KS, Renoir JM. J Steroid Biochem Mol Biol; 2005 Feb 13; 94(1-3):71-81. PubMed ID: 15862952 [Abstract] [Full Text] [Related]
19. Potentiation of glucocorticoid receptor-mediated gene expression by heat and chemical shock. Sanchez ER, Hu JL, Zhong S, Shen P, Greene MJ, Housley PR. Mol Endocrinol; 1994 Apr 13; 8(4):408-21. PubMed ID: 8052262 [Abstract] [Full Text] [Related]